Data from COG protocol AALL0031. Shown are data with long-term follow-up of patients from COG protocol AALL0031 with Ph+ leukemia with no difference in 5-year DFS for patients in Cohort 5 (treated with continuous imatinib plus multiagent chemotherapy) compared with hematopoietic SCT in all cohorts, either from a related or unrelated donor. (Used with permission from Schultz et al, 2014.⁶⁷ )